CalciMedica, Inc.
CALC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534133
No open-market purchases or sales by CalciMedica, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $8.39M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding CalciMedica, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 20 | 21 | +1 |
| Shares | 3.55M | 2.97M | −574.6K (−16.2%) |
| Value | $14.8M | $11.8M | −$2.99M (−20.2%) |
New holders (6)
Institutions that held CalciMedica, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Envestnet Asset Management Inc | 22,256 | $88.1K | 0.00% |
| J. Goldman & Co LP | 18,900 | $74.8K | 0.00% |
| Tritonpoint Wealth, LLC | 15,119 | $59.9K | 0.01% |
| BlackRock Inc. | 13,242 | $52.4K | 0.00% |
| Atria Investments LLC | 11,207 | $44.4K | 0.00% |
| Brown Brothers Harriman & Co | 308 | $1.22K | 0.00% |
Sold out (5)
Institutions that held CalciMedica, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Stonepine Capital Management, LLC | 522,602 | $2.17M |
| OrbiMed Advisors LLC | 297,380 | $1.24M |
| Alyeska Investment Group, L.P. | 75,082 | $312.3K |
| ADAR1 Capital Management, LLC | 781 | $3.25K |
| Wells Fargo & Company | 55 | $229 |